Drug profile · INN
donidalorsen sodium
DAWNZERA (AUTOINJECTOR)
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
donidalorsen sodium (DAWNZERA (AUTOINJECTOR)) is an FDA-listed pharmaceutical active ingredient. Associated with IONIS PHARMACEUTICALS INC. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
Frequently asked questions
What is donidalorsen sodium?
donidalorsen sodium (DAWNZERA (AUTOINJECTOR)) is an FDA-listed pharmaceutical active ingredient. Associated with IONIS PHARMACEUTICALS INC. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for donidalorsen sodium?
DAWNZERA (AUTOINJECTOR) is a marketed brand name for donidalorsen sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of donidalorsen sodium?
donidalorsen sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.